Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.44 |
| ▸ | HTR1A | P08908 | 2/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.44 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.44 |
| ▸ | GALR3 | O60755 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447137 | 1.00 | ALOX15 (0.54) | ALOX15CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL23707013 | 0.89 | ALOX15 (0.62) | ALOX15ALDH1A1TSHRGGPS1FDPS | |
| SCHEMBL15727370 | 0.86 | ALOX15 (0.73) | ALOX15ALDH1A1TSHRGGPS1FDPS | |
| SCHEMBL13176163 | 0.86 | ALOX15 (0.73) | ALOX15ALDH1A1TSHRGGPS1FDPS | |
| SCHEMBL20735271 | 0.84 | ALOX15 (0.57) | ALOX15ALDH1A1TSHRGGPS1FDPS | |
| SCHEMBL19919333 | 0.84 | ALOX15 (0.57) | ALOX15ALDH1A1TSHRGGPS1FDPS | |
| SCHEMBL20735116 | 0.82 | ALOX15 (0.54) | ALOX15ALDH1A1TSHRGGPS1FDPS | |
| SCHEMBL20734980 | 0.81 | ALOX15 (0.53) | ALOX15MAPTALDH1A1TSHRGGPS1 | |
| SCHEMBL20734974 | 0.81 | ALOX15 (0.56) | ALOX15ALDH1A1TSHRGGPS1FDPS | |
| SCHEMBL18736150 | 0.81 | ALOX15 (0.56) | ALOX15GAACYP2C19ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11344652-B2 | Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices | THE ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY (US) | 2022-05-31 | — | — | US | claimed |
| US-12208069-B2 | Antibiofilm formulations | ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY (US) | 2025-01-28 | — | — | US | disclosed |
| US-20240130994-A1 | IONIC LIQUID FORMULATIONS FOR TREATING DIABETES | I2O THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| CN-116635023-A | Ionic liquid preparation for treating diabetes | I2O治疗公司 | 2023-08-22 | — | — | CN | disclosed |
| EP-4208160-A1 | IONIC LIQUID FORMULATIONS FOR TREATING DIABETES | I2O Therapeutics, Inc. (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-18 | — | — | US | disclosed |
| US-11344652-B2 | Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices | THE ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY (US) | 2022-05-31 | — | — | US | disclosed |
| US-20220096402-A1 | ANTIBIOFILM FORMULATIONS | UNIV NORTHERN ARIZONA (US) | 2022-03-31 | — | — | US | disclosed |
| EP-3946261-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | President And Fellows Of Harvard College (US) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12208069-B2 | Antibiofilm formulations | GGPS1, FNTA, SGMS1 | ALOX15 146/4885CHRM5 496/4885CHRM1 294/4885 |
| US-20240130994-A1 | IONIC LIQUID FORMULATIONS FOR TREATING DIABETES | GPR119, FABP4, PNLIP | ALOX15 513/4885CHRM5 3069/4885CHRM1 3423/4885 |
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | ALOX15 3128/4885CHRM5 3503/4885CHRM1 4014/4885 |
| US-20220096402-A1 | ANTIBIOFILM FORMULATIONS | GGPS1, FNTA, SGMS1 | ALOX15 146/4885CHRM5 496/4885CHRM1 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.